BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16235018)

  • 1. Ethnic differences in coagulation factor abnormalities after the Fontan procedure.
    Cheung YF; Chay GW; Ma ESK
    Pediatr Cardiol; 2006; 27(1):96-101. PubMed ID: 16235018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation abnormalities in patients with single-ventricle physiology precede the Fontan procedure.
    Odegard KC; McGowan FX; DiNardo JA; Castro RA; Zurakowski D; Connor CM; Hansen DD; Neufeld EJ; del Nido PJ; Laussen PC
    J Thorac Cardiovasc Surg; 2002 Mar; 123(3):459-65. PubMed ID: 11882816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic oxygen saturation and coagulation factor abnormalities before and after the fontan procedure.
    Cheung EW; Chay GW; Ma ES; Cheung YF
    Am J Cardiol; 2005 Dec; 96(11):1571-5. PubMed ID: 16310443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation.
    Jahangiri M; Kreutzer J; Zurakowski D; Bacha E; Jonas RA
    J Thorac Cardiovasc Surg; 2000 Oct; 120(4):778-82. PubMed ID: 11003762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procoagulant and anticoagulant factor abnormalities following the Fontan procedure: increased factor VIII may predispose to thrombosis.
    Odegard KC; McGowan FX; Zurakowski D; Dinardo JA; Castro RA; del Nido PJ; Laussen PC
    J Thorac Cardiovasc Surg; 2003 Jun; 125(6):1260-7. PubMed ID: 12830042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation abnormalities and liver function after hemi-Fontan and Fontan procedures - the importance of hemodynamics in the early postoperative period.
    Procelewska M; Kolcz J; Januszewska K; Mroczek T; Malec E
    Eur J Cardiothorac Surg; 2007 May; 31(5):866-72. PubMed ID: 17329113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation factor abnormalities after the Fontan procedure and its modifications.
    Sluysmans T; Ovaert C; d'Udekem Y; Barrea C
    J Thorac Cardiovasc Surg; 1999 May; 117(5):1038. PubMed ID: 10336350
    [No Abstract]   [Full Text] [Related]  

  • 8. Coagulation factor abnormalities in patients with single-ventricle physiology immediately prior to the Fontan procedure.
    Odegard KC; McGowan FX; Zurakowski D; DiNardo JA; Castro RA; del Nido PJ; Laussen PC
    Ann Thorac Surg; 2002 Jun; 73(6):1770-7. PubMed ID: 12078768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities in liver function and coagulation profile following the Fontan procedure.
    van Nieuwenhuizen RC; Peters M; Lubbers LJ; Trip MD; Tijssen JG; Mulder BJ
    Heart; 1999 Jul; 82(1):40-6. PubMed ID: 10377307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation factor abnormalities after the Fontan procedure and its modifications.
    Jahangiri M; Shore D; Kakkar V; Lincoln C; Shinebourne E
    J Thorac Cardiovasc Surg; 1997 Jun; 113(6):989-92; discussion 992-3. PubMed ID: 9202678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostatic changes following the modified Fontan operation (total cavopulmonary connection).
    Rauch R; Ries M; Hofbeck M; Buheitel G; Singer H; Klinge J
    Thromb Haemost; 2000 May; 83(5):678-82. PubMed ID: 10823261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective longitudinal study of coagulation profiles in children with hypoplastic left heart syndrome from stage I through Fontan completion.
    Odegard KC; Zurakowski D; DiNardo JA; Castro RA; McGowan FX; Neufeld EJ; Laussen PC
    J Thorac Cardiovasc Surg; 2009 Apr; 137(4):934-41. PubMed ID: 19327521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered endothelial function following the Fontan procedure.
    Binotto MA; Maeda NY; Lopes AA
    Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Bilateral Bidirectional Glenn Operation as a Risk Factor Prior to Fontan Completion in Complex Congenital Heart Disease Patients.
    Keizman E; Tejman-Yarden S; Mishali D; Levine S; Borik S; Pollak U; Katz U; Serraf AE
    World J Pediatr Congenit Heart Surg; 2019 Mar; 10(2):174-181. PubMed ID: 30841839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower incidence of procoagulant abnormalities during follow-up after creation of the Fontan circulation in children.
    Rask O; Hanséus K; Ljung R; Strandberg K; Berntorp E
    Cardiol Young; 2009 Apr; 19(2):152-8. PubMed ID: 19195416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic Steatosis in Patients With Single Ventricle and a Fontan Circulation.
    Katz DA; Peck D; Lubert AM; Possner M; Zafar F; Trout AT; Palermo JJ; Anwar N; Dillman JR; Powell AW; Xanthakos SA; Opotowsky AR; Veldtman G; Alsaied T
    J Am Heart Assoc; 2021 May; 10(9):e019942. PubMed ID: 33880928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation profile and liver function in 102 patients after total cavopulmonary connection at mid term follow up.
    Chaloupecký V; Svobodová I; Hadacová I; Tomek V; Hucín B; Tláskal T; Janousek J; Reich O; Skovránek J
    Heart; 2005 Jan; 91(1):73-9. PubMed ID: 15604339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Kidney Function in Survivors Following Fontan Palliation.
    Sharma S; Ruebner RL; Furth SL; Dodds KM; Rychik J; Goldberg DJ
    Congenit Heart Dis; 2016 Dec; 11(6):630-636. PubMed ID: 27106111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation abnormalities after Fontan procedures.
    Monagle P; Andrew M
    J Thorac Cardiovasc Surg; 1998 Mar; 115(3):732-3. PubMed ID: 9535467
    [No Abstract]   [Full Text] [Related]  

  • 20. Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations.
    Cromme-Dijkhuis AH; Henkens CM; Bijleveld CM; Hillege HL; Bom VJ; van der Meer J
    Lancet; 1990 Nov; 336(8723):1087-90. PubMed ID: 1977979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.